Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (5) , 596-600
- https://doi.org/10.1016/0959-8049(94)90527-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Gastric cancer: Chemotherapy of advanced diseaseHematological Oncology, 1992
- Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric CancerAmerican Journal of Clinical Oncology, 1991
- Etoposide, doxorubicin and cisplatin in advanced or metastatic gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerCancer, 1990
- Radical surgery for gastric cancer. A review of the Japanese experienceCancer, 1989
- Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1989
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958